Bacterial Gastroenteritis
Streptococcal Pharyngitis
Cytomegalovirus Disease
Arboviral Encephalitis
Respiratory Syncytial Virus Disease
Cryptococcal Meningitis
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: Jun 17, 2026

Use of Viral Entry Assays and Molecular Docking Analysis for the Identification of Antiviral Candidates against Coxsackievirus A16
Published on: July 15, 2019
Zhao-Hui Yang1, Shao-Fu Yin, Zong-Jiu Zhang
1State Key Laboratory for Molecular Virology and Genetic Engineering, Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing 100050, China.
Understanding Coxsackievirus A group 16 (CVA16) is crucial for controlling hand, foot, and mouth disease (HFMD). Further research and improved diagnostics will aid in prevention and vaccine development.
Area of Science:
Context:
Purpose:
Summary:
Impact: